Nano One Pilot Plant on Target
Mar 22, 2017 12:32 pm UTC| Business
VANCOUVER, British Columbia, March 22, 2017 -- Dan Blondal, CEO of Nano One Materials Corp. (TSX-V:NNO) (Frankfurt:LBMB) (OTC:NNOMF), today announced that all critical components for Nano One’s pilot plant are now in...
OTI Reports Fourth Quarter and Full Year 2016 Financial Results
Mar 22, 2017 12:31 pm UTC| Business
ROSH PINNA, Israel, March 22, 2017 -- On Track Innovations Ltd. (OTI)(NASDAQ:OTIV), a global provider of near field communication (NFC) and cashless payment solutions, reported financial results for the fourth quarter...
Pediatric Market Rises With Increase In Number Of The Younger Population - IndustryARC
Mar 22, 2017 12:31 pm UTC| Business
Hyderabad, India, March 22, 2017 -- The report “Pediatric Market: By Services (Interventional Cardiology, Imaging, Monitoring, Diagnostics); By Region (Americas, Europe, APAC) - Forecast (2017 - 2022)”, published by...
Pediatric Market Rises With Increase In Number Of The Younger Population - IndustryARC
Mar 22, 2017 12:31 pm UTC| Business
Hyderabad, India, March 22, 2017 -- The report “Pediatric Market: By Services (Interventional Cardiology, Imaging, Monitoring, Diagnostics); By Region (Americas, Europe, APAC) - Forecast (2017 - 2022)”, published by...
Mar 22, 2017 12:30 pm UTC| Business
MOUNTAIN VIEW, Calif., March 22, 2017 -- ChemoCentryx, Inc., (Nasdaq:CCXI), a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer, announced today that the...
Cuba Ventures Corp signs exclusive agreement with Tyrval for Cuba hotel industry sales
Mar 22, 2017 12:30 pm UTC| Business
Travelucion Records Monthly Sales in February 2017 of over $192,000 Sen. Jerry Moran (Rep) Introduces Legislation to Restore Trade with Cuba Alfredo Manresa Appointed as Director VANCOUVER, British Columbia, March 22,...
Corium to Participate in BioPharma Dealmakers Webcast on New Innovations in Drug Delivery Technology
Mar 22, 2017 12:30 pm UTC| Business
MENLO PARK, Calif., March 22, 2017 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal...